Sign inJoin waitlistJoin the waitlist

Amar Kishan

Vice-Chair of Clinical and Translational Research · UCLA David Geffen School of Medicine/UCLA Medical Center

Credentials: · · ·

History

Clinical and Translational Research · UCLA David Geffen School of Medicine/UCLA Medical Center
Present
UCLA Health Jonsson Comprehensive Cancer Center Division · UCLA David Geffen School of Medicine/UCLA Medical Center
Present
UCLA David Geffen School of Medicine/UCLA Medical Center
Present

Radiation Oncology
UCLA David Geffen School of Medicine/UCLA Medical Center
2013–2017
Scripps Mercy Hospital
2012–2013
Harvard Medical School
2008–2012
University of California, Berkeley
2004–2008

Research

Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma
Cancer Cell · 2012 · 445 citations
18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging…
The Lancet Oncology · 2019 · 396 citations
Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality
JAMA Oncology · 2019 · 372 citations

Michael Steinberg
144 papers
Daniel Spratt
94 papers
Nicholas Nickols
86 papers
Luca Valle
64 papers · 18 as a resident
Matthew Rettig
62 papers
Robert Reiter
59 papers
Martin Ma
48 papers · 32 as a resident
Jeremie Calais
41 papers
Nicholas Zaorsky
40 papers
PK
Patrick Kupelian
40 papers
CK
Christopher King
39 papers
Soumyajit Roy
36 papers · 36 as a resident

Grants

Reducing Toxicity from Prostate Cancer Radiotherapy Through Genetics and Technology
National Cancer Institute · R37
Contact PI · $1.1M · University of California Los Angeles
2024–2029

Clinical trials

Vascular Optimized Radiotherapy Tuned to Critical Structures for Erectile Function Using High-Precision X-Ray Treatment
Principal investigator · Recruiting · Phase 3
Jonsson Comprehensive Cancer Center
2025–2036
Alpha-Emitting Radionuclide or Beta-Emitting Radionuclide With Metastasis-Directed Stereotactic Body Radiotherapy for the Treatment of Recurrent, Oligometastatic Prostate Adenocarcinoma
Principal investigator · Recruiting · Phase 2
Jonsson Comprehensive Cancer Center
2025–2031
Image-Guidance and Online Adaptation With Stereotactic Body Radiation Therapy for the Treatment of Localized Prostate Cancer, MANTICORE Trial
Principal investigator · Recruiting
Jonsson Comprehensive Cancer Center
2025–2032
Computed Tomography-Guided Stereotactic Body Radiation Therapy With Intrafraction Motion Monitoring for the Treatment of Localized Prostate Cancer, ILLUSION Trial
Principal investigator · Active not recruiting
Jonsson Comprehensive Cancer Center
2025–2036